Clinical Trial Update: A Study of Daratumumab [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating daratumumab for multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Daratumumab (daratumumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Multiple Myeloma | Phase 3 | Status: RECRUITING